WhiteOak Capital Pharma and Healthcare Fund Direct Growth

WhiteOak Capital Pharma and Healthcare Fund Direct Growth

Equity
Sectoral
Very High Risk
1M
6M
1Y
All
NAV: 27 Feb '26
₹14.44
Min. for SIP
₹100
Fund size
₹491.85 Cr
Expense ratio
0.69%

Return calculator

Monthly investment
₹5,000
Over the pastTotal investmentWould've becomeHistoric returnsReturns
3 months₹15,000₹15,219
+1.46%
6 months₹30,000₹30,394
+1.31%
1 year₹60,000₹62,970
+4.95%

Holdings (57)

NameSectorInstrumentsAssets
Sun Pharmaceutical Industries Ltd.HealthcareEquity10.72%
JB Chemicals & Pharmaceuticals Ltd.HealthcareEquity9.11%
Divi's Laboratories Ltd.HealthcareEquity5.48%
Fortis Healthcare Ltd.HealthcareEquity5.33%
Lupin Ltd.HealthcareEquity5.16%
Apollo Hospitals Enterprise Ltd.HealthcareEquity4.90%
Max Healthcare Institute Ltd.HealthcareEquity4.52%
Laurus Labs Ltd.HealthcareEquity4.41%
Alkem Laboratories Ltd.HealthcareEquity3.36%
Krishna Institute of Medical Sciences LtdHealthcareEquity2.71%
Ajanta Pharma Ltd.HealthcareEquity2.56%
Neuland Laboratories Ltd.HealthcareEquity2.25%
Sai Life Sciences Ltd.HealthcareEquity2.05%
CORONA Remedies Ltd.HealthcareEquity2.03%
Acutaas Chemicals Ltd.HealthcareEquity1.97%
Narayana Hrudayalaya Ltd.HealthcareEquity1.93%
Shaily Engineering Plastics Ltd.ChemicalsEquity1.90%
Abbott India Ltd.HealthcareEquity1.78%
Navin Fluorine International Ltd.ChemicalsEquity1.70%
Vijaya Diagnostic Centre Ltd.HealthcareEquity1.68%
Emcure Pharmaceuticals Ltd.HealthcareEquity1.55%
Astrazeneca Pharma India Ltd.HealthcareEquity1.55%
Pfizer Ltd.HealthcareEquity1.49%
Eris Lifesciences Ltd.HealthcareEquity1.36%
Kovai Medical Center & Hospital Ltd.HealthcareEquity1.35%
Strides Pharma Science Ltd.HealthcareEquity1.31%
Aether Industries Ltd.ChemicalsEquity1.23%
Thyrocare Technologies Ltd.HealthcareEquity1.03%
Aarti Pharmalabs Ltd.ServicesEquity1.02%
Dr. Reddy's Laboratories Ltd.HealthcareFutures0.98%
Sudeep Pharma Ltd.HealthcareEquity0.98%
Supriya Lifescience Ltd.HealthcareEquity0.94%
Divi's Laboratories Ltd.HealthcareFutures0.90%
Zota Health Care Ltd.HealthcareEquity0.87%
Jupiter Life Line Hospitals Ltd.HealthcareEquity0.82%
Reserve Bank of IndiaFinancialT-Bills0.81%
Cipla Ltd.HealthcareEquity0.80%
Ipca Laboratories Ltd.HealthcareEquity0.78%
Poly Medicure Ltd.HealthcareEquity0.60%
Dr Agarwals Eye Hospital Ltd.HealthcareEquity0.59%
Shilpa Medicare Ltd.HealthcareEquity0.49%
Mankind Pharma Ltd.HealthcareFutures0.47%
Anthem Biosciences Ltd.HealthcareEquity0.42%
Reserve Bank of IndiaFinancialT-Bills0.42%
Apollo Hospitals Enterprise Ltd.HealthcareFutures0.34%
Orchid Pharma Ltd.HealthcareEquity0.32%
Sun Pharmaceutical Industries Ltd.HealthcareFutures0.29%
Max Healthcare Institute Ltd.HealthcareFutures0.26%
Mankind Pharma Ltd.HealthcareEquity0.24%
Reserve Bank of IndiaFinancialT-Bills0.20%
Reserve Bank of IndiaFinancialT-Bills0.20%
Reserve Bank of IndiaFinancialT-Bills0.19%
Fortis Healthcare Ltd.HealthcareFutures0.17%
Reserve Bank of IndiaFinancialT-Bills0.14%
Reserve Bank of IndiaFinancialT-Bills0.08%
Reserve Bank of IndiaFinancialT-Bills0.08%
Reserve Bank of IndiaFinancialT-Bills0.04%
See All

Minimum investments

Min. for 1st investment
₹500
Min. for 2nd investment
₹500
Min. for SIP
₹100

Returns and rankings

Annualised returns
Absolute returns
Name3M6M1YAll
Fund returns-2.5%-1.9%+12.9%+41.9%
Category average (Equity Sectoral)-----2.1%--
Rank (Equity Sectoral)1372--

Exit load, stamp duty and tax

Exit load

Exit load of 1%, if redeemed within 1 months.

Stamp duty on investment: 0.005% (from July 1st, 2020)

from July 1st 2020

Tax implication

If you redeem within one year, returns are taxed at 20%. If you redeem after one year, returns exceeding Rs 1.25 lakh in a financial year are taxed at 12.5%.

Fund management

PB
Piyush Baranwal
Jan 2024 - Present
View details

About WhiteOak Capital Pharma and Healthcare Fund Direct Growth

WhiteOak Capital Pharma and Healthcare Fund Direct Growth is a Equity Mutual Fund Scheme launched by WhiteOak Capital Mutual Fund. This scheme was made available to investors on 03 Jul 2018. Piyush Baranwal is the Current Fund Manager of WhiteOak Capital Pharma and Healthcare Fund Direct Growth fund. The fund currently has an Asset Under Management(AUM) of ₹32,686 Cr and the Latest NAV as of 27 Feb 2026 is ₹14.44. The WhiteOak Capital Pharma and Healthcare Fund Direct Growth is rated Very High risk. Minimum SIP Investment is set to ₹100. Minimum Lumpsum Investment is ₹500. Exit load of 1%, if redeemed within 1 months. ;

Investment Objective

The Scheme seeks to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies.
Fund benchmarkBSE Healthcare Total Return Index

Fund house

Rank (total assets)NA
Total AUM₹32,686.09 Cr
Date of Incorporation03 Jul 2018
Phone180030003060
E-mailNA
Launch Date03 Jul 2018
AddressUnit No. B4, 6th Floor,Cnergy, Appasaheb Marathe Marg,Prabhadevi Mumbai 400025
CustodianDeutsche Bank
Registrar & Transfer AgentCams
Address7th Floor, Tower II, Rayala Towers, 158, Anna Salai,